Ajit Kumar Thakur
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Ajit Kumar Thakur has a total of 100 co-authors. Here are the top co-authors by number of shared publications:
Shyam Sunder Chatterjee
Stettiner Straße 1, Karlsruhe, Germany | Pharmacological Research Laboratory, Dr. Willmar Schwabe GmbH & Co Kg, Karlsruhe, Germany
9 shared publicationsNikhila Shekhar
Neuropharmacology Research Laboratory, School of Pharmaceutical Sciences, Delhi Pharmaceutical Sciences and Research University, New Delhi, 110 017 India
7 shared publicationsSakshi Tyagi
Neuropharmacology Research Laboratory, School of Pharmaceutical Sciences, Delhi Pharmaceutical Sciences and Research University, New Delhi, 110 017 India
6 shared publicationsVikas Kumar
6 shared publications- Vikas Kumar
Indian Institute of Technology (Banaras Hindu University)
5 shared publications - Nikhila Shekhar
School of Pharmaceutical Sciences, Delhi Pharmaceutical Sciences and Research University, New Delhi, India
3 shared publications
Latest Publications
- Open Access
- 27 June 2025
- Published by Informatics Publishing Limited in Journal of Natural Remedies
- p. 1375-1393
Anti-Neuropathic Efficacy of Homoeopathic Dilutions of Toxicodendron pubescens: A Preclinical Study
Background: Toxicodendron pubescens Mill., the botanical name of Rhus toxicodendron (Rhus tox), also known as ‘poison ivy’, belongs to the family of Anacardiaceae and is widely used in the traditional system of Homoeopathy medicine. Its crude form and various dilutions are most commonly used to relieve arthritis symptoms, are beneficial as an anti-inflammatory and are also used for edema-related conditions. Aim: The study aims to evaluate the anti-neuropathic efficacy of the crude and diluted forms of Rhus tox, a homoeopathic preparation, using the chronic constriction injury (CCI) rat model. Methods: In the current study, before conducting the in vivo study, the cell viability study on Rhus tox dilutions was determined using the MTT assay with Lipopolysaccharide-treated U-87 glioblastoma cells. Consequently, the effect of the drug on mechanical, cold, and hot allodynia and motor nerve conduction velocity was determined. The levels of antioxidants, proinflammatory markers, and histopathological changes were also evaluated. Results: The 14-day treatment regimen with Rhus tox in the chronic constriction model mitigated behavioural alterations such as mechanical and thermal allodynia with an improvement in the conduction velocity in the sciatic nerve as compared to the corresponding groups. The dilutions were also capable of normalising the altered oxidative and inflammatory markers. The anti-neuropathic efficacy was further confirmed by the improved nerve architecture and reduced infiltration of inflammatory cells in histopathological examination. Conclusion: The present observations support the efficacy of ultra-dilutions of Rhus tox in the rodent CCI model of neuropathic pain through its antioxidant, anti-inflammatory, and modulatory effects on neuropathic pain. Major Findings: Rhus tox showed a cytoprotective effect on LPS-induced U-87 glioblastoma cells. Treatment with Rhus tox in CCI rats attenuated thermal and mechanical allodynia and normalised the nerve conduction. Rhus tox normalised oxidative stress and inflammatory levels, improved nerve architecture, and reduced inflammatory cell infiltration.
- 27 June 2025
- Published by Informatics Publishing Limited in Journal of Natural Remedies
- p. 1375-1393
Open AccessAnti-Neuropathic Efficacy of Homoeopathic Dilutions of Toxicodendron pubescens: A Preclinical Study
Background: Toxicodendron pubescens Mill., the botanical name of Rhus toxicodendron (Rhus tox), also known as ‘poison ivy’, belongs to the family of Anacardiaceae and is widely used in the traditional system of Homoeopathy medicine. Its crude form and various dilutions are most commonly used to relieve arthritis symptoms, are beneficial as an anti-inflammatory and are also used for edema-related conditions. Aim: The study aims to evaluate the anti-neuropathic efficacy of the crude and diluted forms of Rhus tox, a homoeopathic preparation, using the chronic constriction injury (CCI) rat model. Methods: In the current study, before conducting the in vivo study, the cell viability study on Rhus tox dilutions was determined using the MTT assay with Lipopolysaccharide-treated U-87 glioblastoma cells. Consequently, the effect of the drug on mechanical, cold, and hot allodynia and motor nerve conduction velocity was determined. The levels of antioxidants, proinflammatory markers, and histopathological changes were also evaluated. Results: The 14-day treatment regimen with Rhus tox in the chronic constriction model mitigated behavioural alterations such as mechanical and thermal allodynia with an improvement in the conduction velocity in the sciatic nerve as compared to the corresponding groups. The dilutions were also capable of normalising the altered oxidative and inflammatory markers. The anti-neuropathic efficacy was further confirmed by the improved nerve architecture and reduced infiltration of inflammatory cells in histopathological examination. Conclusion: The present observations support the efficacy of ultra-dilutions of Rhus tox in the rodent CCI model of neuropathic pain through its antioxidant, anti-inflammatory, and modulatory effects on neuropathic pain. Major Findings: Rhus tox showed a cytoprotective effect on LPS-induced U-87 glioblastoma cells. Treatment with Rhus tox in CCI rats attenuated thermal and mechanical allodynia and normalised the nerve conduction. Rhus tox normalised oxidative stress and inflammatory levels, improved nerve architecture, and reduced inflammatory cell infiltration.
- 11 June 2025
- Published by Bentham Science Publishers Ltd. in Current Psychopharmacology
- Vol. 13, 1-11
Potential of Andrographolide and Andrographis paniculata Extracts for the Management of Diabetes-associated Psychopathologies: Current Status
Despite the availability of numerous anti-hyperglycemic and psychoactive drugs, and diverse therapeutic modalities, prevention and cure of diabetes-associated mental health problems continue to be a major challenge for medical practitioners. Considerable efforts have been made in many research laboratories, including ours, to identify the bioactive of traditionally known medicinal or food plants to identify their bioactive that could be used for the treatment of diabetes and comorbidities in metabolic disorders. Andrographis paniculata (Burm. F.) Wall. Ex. Nees. has been used in Ayurvedic and other traditionally known healthcare systems of India and many other Asian countries. Due to its extremely bitter taste, it is often referred to as the “king of bitters” and commonly known as “Kalmegh”. Andrographolide is one such metabolite of Andrographis paniculata used in many Asiatic countries for the treatment of diverse age and lifestyle-associated chronic diseases now used for discovering and developing anti-diabetic and other drugs. Available data on andrographolide and Andrographis paniculata strongly recommend that they could be better therapeutic choices for the prevention of diabetes and associated mental health problems than metformin and other pharmacotherapeutics currently commercialized for such purposes. However, the question of whether andrographolide or extracts of the plant enriched in it could be better suited for such purposes remains open. Currently, available quantitative data on their anti-hyperglycemic effects and brain function-modulating effects useful for answering this question are discussed in this report in light of our current knowledge of the role of gut microbiota in regulating glucose homeostasis and mental health. Their potential uses for discovering and developing drugs or phytotherapeutics from them are also pointed out.
- 11 June 2025
- Published by Bentham Science Publishers Ltd. in Current Psychopharmacology
- Vol. 13, 1-11
Potential of Andrographolide and Andrographis paniculata Extracts for the Management of Diabetes-associated Psychopathologies: Current Status
Despite the availability of numerous anti-hyperglycemic and psychoactive drugs, and diverse therapeutic modalities, prevention and cure of diabetes-associated mental health problems continue to be a major challenge for medical practitioners. Considerable efforts have been made in many research laboratories, including ours, to identify the bioactive of traditionally known medicinal or food plants to identify their bioactive that could be used for the treatment of diabetes and comorbidities in metabolic disorders. Andrographis paniculata (Burm. F.) Wall. Ex. Nees. has been used in Ayurvedic and other traditionally known healthcare systems of India and many other Asian countries. Due to its extremely bitter taste, it is often referred to as the “king of bitters” and commonly known as “Kalmegh”. Andrographolide is one such metabolite of Andrographis paniculata used in many Asiatic countries for the treatment of diverse age and lifestyle-associated chronic diseases now used for discovering and developing anti-diabetic and other drugs. Available data on andrographolide and Andrographis paniculata strongly recommend that they could be better therapeutic choices for the prevention of diabetes and associated mental health problems than metformin and other pharmacotherapeutics currently commercialized for such purposes. However, the question of whether andrographolide or extracts of the plant enriched in it could be better suited for such purposes remains open. Currently, available quantitative data on their anti-hyperglycemic effects and brain function-modulating effects useful for answering this question are discussed in this report in light of our current knowledge of the role of gut microbiota in regulating glucose homeostasis and mental health. Their potential uses for discovering and developing drugs or phytotherapeutics from them are also pointed out.
- 24 May 2025
- Published by Springer Nature in Cytotechnology
- Vol. 77 (3) , 107
Ameliorative potential of metformin in LPS and glutamate-induced neurotoxicity in N2a cell-line
The study aims to explore the potential of metformin to counteract the lethal effects of glutamate and lipopolysaccharide (LPS)- induced neurotoxicity in Neuro2a (N2a) cells, resembling CNS-comorbidities generally associated with metabolic disorders. Glutamate and LPS-induced N2a cell models were used to conduct the in-vitro study to evaluate the beneficial effect of metformin. Cell viability assay, biochemical parameter viz. cytokines level, superoxide dismutase (SOD) was performed. Further, reactive oxygen species (ROS) were also staged using the Fluorescence-Activated Cell Sorting (FACS) technique to evaluate the beneficial effect of metformin on oxidative stress. Metformin treatments during the study revealed neuroprotective effects and abridged neurotoxicity by significantly reducing the levels of cytokines (viz. IL-1β, IL-6, and TNF-α), raising SOD enzyme activities and declining the ROS levels in LPS and glutamate-treated N2a cells. Based on experimental observation, in an in-vitro study, the effective dose of Met was 50 µM. The results showed that metformin had a neuroprotective effect by enhancing cell viability, diminishing the cytokine storm, and reducing various oxidative stressors. These findings imply that due to the anti-inflammatory, diminishing reactive oxidative species, and antioxidant properties of metformin, it can be considered a therapeutic drug candidate for treating and managing neurological disorders and CNS complications associated with metabolic abnormalities. Further, an in-vivo mechanistic study is warranted to validate the safety and efficacy of metformin for neurological disorders associated with metabolic abnormalities and neurodegenerative disorders.
- 24 May 2025
- Published by Springer Nature in Cytotechnology
- Vol. 77 (3) , 107
Ameliorative potential of metformin in LPS and glutamate-induced neurotoxicity in N2a cell-line
The study aims to explore the potential of metformin to counteract the lethal effects of glutamate and lipopolysaccharide (LPS)- induced neurotoxicity in Neuro2a (N2a) cells, resembling CNS-comorbidities generally associated with metabolic disorders. Glutamate and LPS-induced N2a cell models were used to conduct the in-vitro study to evaluate the beneficial effect of metformin. Cell viability assay, biochemical parameter viz. cytokines level, superoxide dismutase (SOD) was performed. Further, reactive oxygen species (ROS) were also staged using the Fluorescence-Activated Cell Sorting (FACS) technique to evaluate the beneficial effect of metformin on oxidative stress. Metformin treatments during the study revealed neuroprotective effects and abridged neurotoxicity by significantly reducing the levels of cytokines (viz. IL-1β, IL-6, and TNF-α), raising SOD enzyme activities and declining the ROS levels in LPS and glutamate-treated N2a cells. Based on experimental observation, in an in-vitro study, the effective dose of Met was 50 µM. The results showed that metformin had a neuroprotective effect by enhancing cell viability, diminishing the cytokine storm, and reducing various oxidative stressors. These findings imply that due to the anti-inflammatory, diminishing reactive oxidative species, and antioxidant properties of metformin, it can be considered a therapeutic drug candidate for treating and managing neurological disorders and CNS complications associated with metabolic abnormalities. Further, an in-vivo mechanistic study is warranted to validate the safety and efficacy of metformin for neurological disorders associated with metabolic abnormalities and neurodegenerative disorders.
- 31 January 2025
- Published by Elsevier
Contributors
- 31 January 2025
- Published by Elsevier
- p. 297-323
Role of microbiome gut-brain axis in brain disorders
- 31 December 2024
- Published by Wiley in Developmental Neurobiology
- Vol. 85 (1) , e22959
Investigating the Effect of Capric Acid on Antibiotic‐Induced Autism‐Like Behavior in Rodents
Owing to the high prevalence of gastrointestinal dysfunction in patients, the gut–brain axis is considered to play a vital role in neurodevelopment diseases. Recent pieces of evidence have pointed to the usage of antibiotics at an early developmental stage to be a causative factor in autism due to its ability to induce critical changes in the gut microbiota. The purpose of the study is to determine the neuroprotective effect of capric acid (CA) on autism in antibiotic‐induced gut dysbiosis in rodents. In this study, the effect of CA was observed in penicillin V (31 mg/kg, p.o.) exposed animals by evaluating their autism‐like behavioral and biochemical parameters. The establishment of gut dysbiosis was confirmed by 16 RNA sequencing, and behavioral tests were performed. Subsequently, oxidative stress, cytokine levels, and mitochondrial complex activities in the hippocampus and prefrontal cortex were analyzed. It was observed that the administration of penicillin V during the perinatal period produced gut dysbiosis and long‐lasting changes in social behavior with symptoms of anxiety and depression and impaired learning and memory. Treatment with penicillin V also produced oxidative stress, mitochondrial dysfunction, and inflammation in the hippocampus and prefrontal cortex. Treatment with CA produced a positive effect on the alterations with maximum effects evident at 400 mg/kg, p.o. through amelioration of behavioral as well as biochemical changes. The current study concluded that CA could act as a likely candidate for the treatment and management of autism via modulation of gut dysbiosis‐induced neurobehavioral parameters, oxidative stress, mitochondrial dysfunction, and inflammatory markers.
- 31 December 2024
- Published by Wiley in Developmental Neurobiology
- Vol. 85 (1) , e22959
Investigating the Effect of Capric Acid on Antibiotic‐Induced Autism‐Like Behavior in Rodents
Owing to the high prevalence of gastrointestinal dysfunction in patients, the gut–brain axis is considered to play a vital role in neurodevelopment diseases. Recent pieces of evidence have pointed to the usage of antibiotics at an early developmental stage to be a causative factor in autism due to its ability to induce critical changes in the gut microbiota. The purpose of the study is to determine the neuroprotective effect of capric acid (CA) on autism in antibiotic‐induced gut dysbiosis in rodents. In this study, the effect of CA was observed in penicillin V (31 mg/kg, p.o.) exposed animals by evaluating their autism‐like behavioral and biochemical parameters. The establishment of gut dysbiosis was confirmed by 16 RNA sequencing, and behavioral tests were performed. Subsequently, oxidative stress, cytokine levels, and mitochondrial complex activities in the hippocampus and prefrontal cortex were analyzed. It was observed that the administration of penicillin V during the perinatal period produced gut dysbiosis and long‐lasting changes in social behavior with symptoms of anxiety and depression and impaired learning and memory. Treatment with penicillin V also produced oxidative stress, mitochondrial dysfunction, and inflammation in the hippocampus and prefrontal cortex. Treatment with CA produced a positive effect on the alterations with maximum effects evident at 400 mg/kg, p.o. through amelioration of behavioral as well as biochemical changes. The current study concluded that CA could act as a likely candidate for the treatment and management of autism via modulation of gut dysbiosis‐induced neurobehavioral parameters, oxidative stress, mitochondrial dysfunction, and inflammatory markers.
- 30 May 2024
- Published by Springer Nature in Neurochemical Research
- Vol. 49 (8) , 2038-2059
Effect of Capsaicin on 3-NP-Induced Neurotoxicity: A Pre-Clinical Study
The study objectives are to investigate the ability of capsaicin to revert the toxic effects in glutamate and lipopolysaccharide (LPS)-induced neurotoxicity in Neuro2a (N2a) cells as well as thwarting cognitive impairments, mitochondrial deficits, and oxidative insults induced by 3-nitropropanoic acid (3-NP) in a rodent model of Huntington’s disease. In-vitro study with N2a cells was performed through MTT and LDH assay and their biochemical examinations were also performed. 3-NP-administered mice (n = 6) were treated with capsaicin (5, 10, and 20 mg/kg) through the per-oral (p.o.) route for 7 consecutive days. Physiological and behavioral studies were performed in drug-treated mice. After behavioral studies, biochemical parameters were performed for cytokines levels, various oxidative stress parameters, and mitochondrial enzyme complex activities with mitochondrial permeability. N2a cells treated with capsaicin demonstrated neuroprotective effects and reduced neurotoxicity. Based on experimental observation, in an in-vitro study, the effective dose of CAP was 50 µM. Moreover, a 100 µM dose of capsaicin had toxic effects on neuronal cells (N2a cells). On the other hand, the effective dose of 3-NP was 20 mg/kg, (p.o.) in animals (in-vivo). All tested doses of capsaicin upturned the cognitive impairment and motor in-coordination effects induced by 3-NP. 3-NP-injected mice demonstrated substantially increased pro-inflammatory cytokine concentrations, defective mitochondrial complex activity, and augmented oxidative insult. However, capsaicin at different doses reduced oxidative damage and cytokines levels and improved mitochondrial complex activity along with mitochondrial permeability. Furthermore, capsaicin (10 and 20 mg/kg) improved the TNF-α concentration. These findings suggested because of the anti-inflammatory and antioxidant effect, capsaicin can be considered a novel treatment for the management of neurodegenerative disorders by reverting the antioxidant enzyme activity, pro-inflammatory cytokines concentration, and mitochondrial functions.
- 30 May 2024
- Published by Springer Nature in Neurochemical Research
- Vol. 49 (8) , 2038-2059
Effect of Capsaicin on 3-NP-Induced Neurotoxicity: A Pre-Clinical Study
The study objectives are to investigate the ability of capsaicin to revert the toxic effects in glutamate and lipopolysaccharide (LPS)-induced neurotoxicity in Neuro2a (N2a) cells as well as thwarting cognitive impairments, mitochondrial deficits, and oxidative insults induced by 3-nitropropanoic acid (3-NP) in a rodent model of Huntington’s disease. In-vitro study with N2a cells was performed through MTT and LDH assay and their biochemical examinations were also performed. 3-NP-administered mice (n = 6) were treated with capsaicin (5, 10, and 20 mg/kg) through the per-oral (p.o.) route for 7 consecutive days. Physiological and behavioral studies were performed in drug-treated mice. After behavioral studies, biochemical parameters were performed for cytokines levels, various oxidative stress parameters, and mitochondrial enzyme complex activities with mitochondrial permeability. N2a cells treated with capsaicin demonstrated neuroprotective effects and reduced neurotoxicity. Based on experimental observation, in an in-vitro study, the effective dose of CAP was 50 µM. Moreover, a 100 µM dose of capsaicin had toxic effects on neuronal cells (N2a cells). On the other hand, the effective dose of 3-NP was 20 mg/kg, (p.o.) in animals (in-vivo). All tested doses of capsaicin upturned the cognitive impairment and motor in-coordination effects induced by 3-NP. 3-NP-injected mice demonstrated substantially increased pro-inflammatory cytokine concentrations, defective mitochondrial complex activity, and augmented oxidative insult. However, capsaicin at different doses reduced oxidative damage and cytokines levels and improved mitochondrial complex activity along with mitochondrial permeability. Furthermore, capsaicin (10 and 20 mg/kg) improved the TNF-α concentration. These findings suggested because of the anti-inflammatory and antioxidant effect, capsaicin can be considered a novel treatment for the management of neurodegenerative disorders by reverting the antioxidant enzyme activity, pro-inflammatory cytokines concentration, and mitochondrial functions.
- 13 May 2024
- Published by Elsevier in Neurochemistry International
- Vol. 177, 105767
Evaluation of the protective effect of capric acid on behavioral and biochemical alterations in valproic acid-induced model of autism
- 13 May 2024
- Published by Elsevier in Neurochemistry International
- Vol. 177, 105767
Evaluation of the protective effect of capric acid on behavioral and biochemical alterations in valproic acid-induced model of autism
- 10 February 2024
- Published by Springer Nature in Neuroscience and Behavioral Physiology
- Vol. 55 (1) , 1-15
Beneficial role of capsaicin through modulation of mitochondrial functions in MPTP-injected mice
- 10 February 2024
- Published by Springer Nature in Neuroscience and Behavioral Physiology
- Vol. 55 (1) , 1-15
Beneficial role of capsaicin through modulation of mitochondrial functions in MPTP-injected mice
- 1 February 2024
- Published by Bentham Science Publishers Ltd. in Current Psychiatry Research and Reviews
- Vol. 20 (1) , 14-36
Alternative Approaches for the Management of Autism: A Narrative Review
Autism, a neurodevelopment disorder that was regarded as insignificant in the past is thereby now recognized as a major problem with an increasing prevalence over the past 50 years affecting 1 out of every 160 children worldwide. Recent accumulating evidence indicates that autism is a consequence of the fusion of environmental, genetic, and epigenetic components. Due to the lack of effective pharmacotherapy, alternative approaches are being explored for their beneficial effect on autistic symptoms. A literature review was performed identifying previously published clinical studies that were set up as an alternative therapy for alleviating the symptoms of autism. The data were collected from PubMed and Google Scholar databases. A total of 13 kinds of interventions including video modelling, play therapy, music therapy, yoga, social skills training, sensory integration (SIT), scalp acupuncture, medical clowning, animal-assisted activity, theatre-based intervention, Tai Chu Chuan training, novel mattress technology, and magnetic resonance imaging were found to be affecting the symptoms associated with autism. From sufficient clinical evidence, it was estimated that alternative approaches such as music therapy and play therapy have the most beneficial effect in mitigating the symptoms to an extent.
- 1 February 2024
- Published by Bentham Science Publishers Ltd. in Current Psychiatry Research and Reviews
- Vol. 20 (1) , 14-36
Alternative Approaches for the Management of Autism: A Narrative Review
Autism, a neurodevelopment disorder that was regarded as insignificant in the past is thereby now recognized as a major problem with an increasing prevalence over the past 50 years affecting 1 out of every 160 children worldwide. Recent accumulating evidence indicates that autism is a consequence of the fusion of environmental, genetic, and epigenetic components. Due to the lack of effective pharmacotherapy, alternative approaches are being explored for their beneficial effect on autistic symptoms. A literature review was performed identifying previously published clinical studies that were set up as an alternative therapy for alleviating the symptoms of autism. The data were collected from PubMed and Google Scholar databases. A total of 13 kinds of interventions including video modelling, play therapy, music therapy, yoga, social skills training, sensory integration (SIT), scalp acupuncture, medical clowning, animal-assisted activity, theatre-based intervention, Tai Chu Chuan training, novel mattress technology, and magnetic resonance imaging were found to be affecting the symptoms associated with autism. From sufficient clinical evidence, it was estimated that alternative approaches such as music therapy and play therapy have the most beneficial effect in mitigating the symptoms to an extent.